Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lilly(Eli) & Co shares valued at $716,410 were sold by Zakrowski Donald A on May 27 ’25. At $716.41 per share, Zakrowski Donald A sold 1,000 shares. The insider’s holdings dropped to 4,840 shares worth approximately $3.5 million following the completion of this transaction.
Also, Yuffa Ilya sold 1,250 shares, netting a total of over 936,550 in proceeds. Following the sale of shares at $749.24 each, the insider now holds 27,510 shares.
Before that, Yuffa Ilya had added 2,500 shares to its account. In a trade valued at $1,873,100, the Officer bought Lilly(Eli) & Co shares for $749.24 each.
As published in a research note from HSBC Securities on April 28, 2025, Lilly(Eli) & Co [LLY] has been rated down from a Buy to a Reduce and the price target has been revised to $700 from $1150. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. Earlier on November 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for LLY stock.
Analyzing LLY Stock Performance
During the last five days, there has been a drop of approximately -0.33%. Over the course of the year, Lilly(Eli) & Co shares have dropped approximately -6.40%. Shares of the company reached a 52-week high of $935.63 on 03/03/25 and a 52-week low of $677.09 on 04/07/25.
Support And Resistance Levels for Lilly(Eli) & Co (LLY)
According to the 24-hour chart, there is a support level at 717.24, which, if violated, would cause prices to drop to 711.91. In the upper region, resistance lies at 727.61. The next price resistance is at 732.66. RSI (Relative Strength Index) is 41.16 on the 14-day chart, showing neutral technical sentiment.
